Medpace Holdings Inc buy melinda
Start price
08.03.17
/
50%
€26.02
Target price
04.04.17
€32.47
Performance (%)
4.44%
End price
04.04.17
€27.18
Summary
This prediction ended on 04.04.17 with a price of €27.18. With a performance of 4.44%, the BUY prediction by melinda for Medpace Holdings Inc closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Medpace Holdings Inc | 5.323% | 5.323% | 34.452% | 87.186% |
iShares Core DAX® | -1.114% | 5.062% | 24.922% | 25.215% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% | 44.324% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% | 12.395% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% | 43.899% |
According to melinda what are the pros and cons of Medpace Holdings Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Medpace Holdings Inc diskutieren
medizinische Geräte
Medpace Holdings, Inc. engagiert in der Forschung, Entwicklung und Handel von Medizinprodukten und pharmazeutischen products.Its Dienstleistungen umfassen klinische Operationen, Medical Writing und Überprüfung, Biometrie, Pharmakovigilanz, Imaging - Kernlabor, klinische Pharmakologie, Interactive Voice Response System
(Vom Mitglied beendet)
Stopped prediction by melinda for Medpace Holdings Inc
Medpace Holdings Inc
Start price
Target price
Perf. (%)
€218.90
25.10.22
25.10.22
€190.00
25.10.23
25.10.23
11.47%
26.10.23
26.10.23
Could be worthwhile Investment >10% per year
Medpace Holdings Inc
Start price
Target price
Perf. (%)
€91.00
24.09.20
24.09.20
€145.00
04.11.21
04.11.21
114.29%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year